Justin Worland of TIME reports on a new MIT study examining the public health impacts of Volkswagen’s software designed to evade emissions standards. “The emissions problem will also add nearly half a billion dollars in social costs,” writes Worland.
Alexandra Ossola reports for Popular Science that MIT researchers have determined that by cheating on emissions tests, Volkswagen could cause 60 premature deaths in the U.S. “The researchers estimated the impact on public health…by calculating the effects of more fine particulates, ozone, and nitrous oxide,” writes Ossola.
Researchers at MIT and Harvard have determined that emissions resulting from Volkswagen’s rigged inspections will cause 60 premature deaths in the U.S., reports Robert Preidt for U.S. News & World Report. The researchers found that “if VW recalls every affected vehicle by the end of 2016, more than 130 additional deaths may be prevented,” writes Preidt.
CNBC reporter Robert Ferris writes about a study by researchers from MIT and Harvard that examines the impacts of Volkswagen cheating on emissions tests. “Volkswagen's cars have emitted 40 times the amount of noxious nitrogen oxide (NOx) than the limit proscribed by the U.S. Environmental Protection Agency,” Ferris explains.
Nina Godlewski writes for Boston.com that a new study co-authored by MIT researchers found that approximately 60 people in the U.S. will die prematurely due to Volkswagen’s cheating on emissions tests. Godlewski explains that, “if the automaker fails to recall all of the affected vehicles by the end of 2016, more deaths may occur.”
Atlantic reporter Robinson Meyer speaks with Prof. Steven Barrett about his research showing that 140 people will die prematurely if Volkswagen vehicles outfitted with emissions-cheating devices are not recalled. Barrett says that if the cars are returned, “most of those 140 deaths would be averted.”
In an article for Stat, Andrew Joseph writes that the Commonwealth Foundation for Cancer Research is committing $20 million to the Bridge Project, which funds research at the Koch Institute and Dana-Farber. “We’re looking for the best people, regardless of where they are, to tackle these very important problems,” explains Tyler Jacks, director of the Koch Institute.
In this BBC News segment, Prof. Robert Langer, winner of the Queen Elizabeth Prize for Engineering, discusses his work exploring how to get the human body to respond to vital drugs. Langer explains that his approach to medicine is to “come up with engineering solutions to different medical problems.”
MIT researchers have developed a self-sustaining water-purification system for a remote Mexican village, according to The Guardian. “The villagers are able to operate and maintain the water purification system themselves,” The Guardian reports.
Forbes reporter Jennifer Hicks writes about MIT spinoff EyeNetra, which is developing a self-diagnostic eye test could lead to customized, virtual-reality screens. “EyeNetra’s technology measures how a user’s optical refractive errors will affect how they see patterns on a digital display, just like a VR headset,” Hicks explains.
Lindsay Kalter reports for The Boston Herald that researchers from MIT, Philips, and Boston Medical Center are developing a non-invasive way to diagnose head injuries. Kalter explains that the study is part of a new collaboration between MIT and Philips and will “use data from an ultrasound machine taking measurements of blood pressure and flow.”
Researchers from MIT, Philips and Boston Medical Center are collaborating on new technology to diagnose brain injuries, reports Nidhi Subbaraman for BetaBoston. “The goal is to investigate whether ultrasound readers can help doctors assess the severity of a head injury,” Subbaraman writes.
In an article for The New York Times about the impact of patent laws on drug development, Austin Frakt highlights Prof. Benjamin Roin’s research that indicates pharmaceutical companies reject unpatentable drugs. To counter this problem, Frakt explains that Roin suggests “a period of market exclusivity…to any organization addressing an unmet medical need with a drug that isn’t patentable.”
Charlotte Lytton writes for The Daily Beast about SenseGlass, a mirror created by graduate student Javier Hernandez that uses Google Glass technology to register physiological and emotional changes in the viewer. “I believe mirrors are a great platform for health monitoring as we use them [everyday],” says Hernandez.
Margot Sanger-Katz of The New York Times writes about Professor Amy Finkelstein’s survey of low-income Oregonians in which she determined that those given access to Medicaid spent more on healthcare than the uninsured. “There’s overwhelming evidence from our study and others that when you cover people with health insurance, they use more health care,” said Finkelstein.